Qingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.
01 3Sichuan Qingmu Pharmaceutical
02 7H. Lundbeck AS
03 2Hikma Pharmaceuticals
04 1Indivior
05 2Purdue Pharmaceuticals L.P
01 6Film Coated Tablet
02 1Film-Coated Tablet
03 6SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
04 1SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
05 1SPRAY;NASAL
01 1Allowed
02 1Approved
03 2Authorized
04 2DISCN
05 2Marketed
06 1Prescription
07 5RX
08 1Blank
01 4NALMEFENE HYDROCHLORIDE
02 1OPVEE
03 2REVEX
04 7Selincro
05 1ZURNAI (AUTOINJECTOR)
01 1Estonia
02 2Norway
03 2Spain
04 1Sweden
05 1Switzerland
06 8USA
Qingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : NALMEFENE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
Packaging :
Approval Date : 2023-11-15
Application Number : 216007
Regulatory Info : RX
Registration Country : USA
Qingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : NALMEFENE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : EQ 2MG BASE/2ML (EQ 1MG BASE/ML)
Packaging :
Approval Date : 2023-11-15
Application Number : 216007
Regulatory Info : RX
Registration Country : USA
Qingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.
Regulatory Info :
Registration Country : USA
Brand Name : NALMEFENE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 2MG BASE/2ML (EQ 1MGBASE/ML)
Packaging :
Approval Date :
Application Number : 216007
Regulatory Info :
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Nalmefene Hydrochloride Dihydrate
Brand Name : Selincro
Dosage Form : Film Coated Tablet
Dosage Strength : 18mg
Packaging :
Approval Date : 25/02/2013
Application Number : 20120120000033
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Selincro
Dosage Form : Film Coated Tablet
Dosage Strength : 186mg
Packaging :
Approval Date : 15/04/2014
Application Number : 62764
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Marketed
Registration Country : Norway
Nalmefene hydrochloride dihydrate
Brand Name : Selincro
Dosage Form : Film Coated Tablet
Dosage Strength : 18mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Nalmefene hydrochloride dihydrate
Brand Name : Selincro
Dosage Form : Film Coated Tablet
Dosage Strength : 18mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Estonia
Brand Name : Selincro
Dosage Form : Film-Coated Tablet
Dosage Strength : 18mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Selincro
Dosage Form : Film Coated Tablet
Dosage Strength : 18MG
Packaging :
Approval Date : 30-04-2013
Application Number : 112815002
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Selincro
Dosage Form : Film Coated Tablet
Dosage Strength : 18MG
Packaging :
Approval Date : 20-11-2024
Application Number : 112815002IP
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REVEX
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1995-04-17
Application Number : 20459
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REVEX
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : EQ 2MG BASE/2ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1995-04-17
Application Number : 20459
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OPVEE
Dosage Form : SPRAY;NASAL
Dosage Strength : EQ 2.7MG BASE/SPRAY
Packaging :
Approval Date : 2023-05-22
Application Number : 217470
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NALMEFENE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : EQ 2MG BASE/2ML (EQ 1MG BASE/ML)
Packaging :
Approval Date : 2022-02-08
Application Number : 212955
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ZURNAI (AUTOINJECTOR)
Dosage Form : SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
Dosage Strength : EQ 1.5MG BASE/0.5ML (EQ 1.5MG BASE/0.5ML)
Packaging :
Approval Date : 2024-08-07
Application Number : 218590
Regulatory Info : RX
Registration Country : USA
